Literature DB >> 27306906

Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1.

Marija Cvetanovic1, Yuan-Shih Hu2, Puneet Opal3,4.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease caused by the expansion of a polyglutamine (Q) repeat tract in the protein ataxin-1 (ATXN1). Beginning as a cerebellar ataxic disorder, SCA1 progresses to involve the cerebral cortex, hippocampus, and brainstem. Using SCA1 knock-in mice that mirror the complexity of the human disease, we report a significant decrease in the capacity of adult neuronal progenitor cells (NPCs) to proliferate. Remarkably, a decrease in NPCs proliferation can be observed in vitro, outside the degenerative milieu of surrounding neurons or glia, demonstrating that mutant ATXN1 acting cell autonomously within progenitor cells interferes with their ability to proliferate. Our findings suggest that compromised adult neurogenesis contributes to the progressive pathology of the disease particularly in areas such as the hippocampus and cerebral cortex where stem cells provide neurotropic factors and participate in adult neurogenesis. These findings not only shed light on the biology of the disease but also have therapeutic implications in any future stem cell-based clinical trials.

Entities:  

Keywords:  Neurogenesis; Proliferation; SCA1; Spinocerebellar ataxia type 1

Mesh:

Substances:

Year:  2017        PMID: 27306906      PMCID: PMC5510931          DOI: 10.1007/s12311-016-0794-9

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  49 in total

Review 1.  Mechanisms and functional implications of adult neurogenesis.

Authors:  Chunmei Zhao; Wei Deng; Fred H Gage
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

2.  Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice.

Authors:  Michael Demars; Yuan-Shih Hu; Archana Gadadhar; Orly Lazarov
Journal:  J Neurosci Res       Date:  2010-08-01       Impact factor: 4.164

Review 3.  Spinocerebellar ataxia type 1.

Authors:  Stefano Di Donato; Caterina Mariotti; Franco Taroni
Journal:  Handb Clin Neurol       Date:  2012

4.  Self-renewing and differentiating properties of cortical neural stem cells are selectively regulated by basic fibroblast growth factor (FGF) signaling via specific FGF receptors.

Authors:  Dragan Maric; Alessandra Fiorio Pla; Yoong Hee Chang; Jeffery L Barker
Journal:  J Neurosci       Date:  2007-02-21       Impact factor: 6.167

5.  Transient expression of doublecortin during adult neurogenesis.

Authors:  Jason P Brown; Sébastien Couillard-Després; Christiana M Cooper-Kuhn; Jürgen Winkler; Ludwig Aigner; H Georg Kuhn
Journal:  J Comp Neurol       Date:  2003-12-01       Impact factor: 3.215

6.  The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1.

Authors:  Anand Venkatraman; Yuan-Shih Hu; Alessandro Didonna; Marija Cvetanovic; Aleksandar Krbanjevic; Patrice Bilesimo; Puneet Opal
Journal:  Hum Mol Genet       Date:  2014-03-04       Impact factor: 6.150

7.  Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis.

Authors:  Laure Verret; Joanna L Jankowsky; Guilian M Xu; David R Borchelt; Claire Rampon
Journal:  J Neurosci       Date:  2007-06-20       Impact factor: 6.167

8.  Aberrant hippocampal neurogenesis contributes to epilepsy and associated cognitive decline.

Authors:  Kyung-Ok Cho; Zane R Lybrand; Naoki Ito; Rebecca Brulet; Farrah Tafacory; Ling Zhang; Levi Good; Kerstin Ure; Steven G Kernie; Shari G Birnbaum; Helen E Scharfman; Amelia J Eisch; Jenny Hsieh
Journal:  Nat Commun       Date:  2015-03-26       Impact factor: 14.919

9.  Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 mice.

Authors:  Yuan-Shih Hu; Peng Xu; Gustavo Pigino; Scott T Brady; John Larson; Orly Lazarov
Journal:  FASEB J       Date:  2010-01-19       Impact factor: 5.191

10.  Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.

Authors:  Kei Watase; Jennifer R Gatchel; Yaling Sun; Effat Emamian; Richard Atkinson; Ronald Richman; Hidehiro Mizusawa; Harry T Orr; Chad Shaw; Huda Y Zoghbi
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069

View more
  11 in total

1.  Cerebellar contribution to the cognitive alterations in SCA1: evidence from mouse models.

Authors:  Melissa Asher; Juao-Guilherme Rosa; Orion Rainwater; Lisa Duvick; Michael Bennyworth; Ruo-Yah Lai; Sheng-Han Kuo; Marija Cvetanovic
Journal:  Hum Mol Genet       Date:  2020-01-01       Impact factor: 6.150

2.  Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1.

Authors:  Chandrakanth Reddy Edamakanti; Jeehaeh Do; Alessandro Didonna; Marco Martina; Puneet Opal
Journal:  J Clin Invest       Date:  2018-04-23       Impact factor: 14.808

Review 3.  The extra-cerebellar effects of spinocerebellar ataxia type 1 (SCA1): looking beyond the cerebellum.

Authors:  Victor Olmos; Neha Gogia; Kimberly Luttik; Fatema Haidery; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2022-07-08       Impact factor: 9.207

4.  Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.

Authors:  Jan Cendelin; Marija Cvetanovic; Mandi Gandelman; Hirokazu Hirai; Harry T Orr; Stefan M Pulst; Michael Strupp; Filip Tichanek; Jan Tuma; Mario Manto
Journal:  Cerebellum       Date:  2021-08-10       Impact factor: 3.648

5.  Long-Term Development of Embryonic Cerebellar Grafts in Two Strains of Lurcher Mice.

Authors:  Jan Cendelin; Zdenka Purkartova; Jakub Kubik; Erik Ulbricht; Filip Tichanek; Yaroslav Kolinko
Journal:  Cerebellum       Date:  2018-08       Impact factor: 3.847

Review 6.  Pathogenic mechanisms underlying spinocerebellar ataxia type 1.

Authors:  Leon Tejwani; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2020-04-18       Impact factor: 9.261

7.  Control of CNS functions by RNA-binding proteins in neurological diseases.

Authors:  Yijing Zhou; Fengping Dong; Yingwei Mao
Journal:  Curr Pharmacol Rep       Date:  2018-05-02

8.  Loss of Ataxin-1 Potentiates Alzheimer's Pathogenesis by Elevating Cerebral BACE1 Transcription.

Authors:  Jaehong Suh; Donna M Romano; Larissa Nitschke; Scott P Herrick; Britt A DiMarzio; Volodymyr Dzhala; Jun-Seok Bae; Mary K Oram; Yuejiao Zheng; Basavaraj Hooli; Kristina Mullin; Vincenzo A Gennarino; Wilma Wasco; Jeremy D Schmahmann; Mark W Albers; Huda Y Zoghbi; Rudolph E Tanzi
Journal:  Cell       Date:  2019-08-22       Impact factor: 41.582

9.  Hippocampal mitochondrial dysfunction and psychiatric-relevant behavioral deficits in spinocerebellar ataxia 1 mouse model.

Authors:  Filip Tichanek; Martina Salomova; Jan Jedlicka; Jitka Kuncova; Pavel Pitule; Tereza Macanova; Zuzana Petrankova; Zdenek Tuma; Jan Cendelin
Journal:  Sci Rep       Date:  2020-03-25       Impact factor: 4.379

10.  Antisense Oligonucleotide Therapeutic Approach for Suppression of Ataxin-1 Expression: A Safety Assessment.

Authors:  Brennon O'Callaghan; Bente Hofstra; Hillary P Handler; Holly B Kordasiewicz; Tracy Cole; Lisa Duvick; Jillian Friedrich; Orion Rainwater; Praseuth Yang; Michael Benneyworth; Tessa Nichols-Meade; Wesley Heal; Rachel Ter Haar; Christine Henzler; Harry T Orr
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-25       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.